Shares of Suven Life Sciences will remain active on the bourses as its board of directors are meeting on Monday to consider fund-raising plans through various avenues. The company's board is also considering alteration of its Articles of Association. Though the company did not divulge any details, in the recent AGM, shareholders had approved borrowing up to ₹600 crore. Analysts will be keen to know the quantum, mode and timing of the issue.

comment COMMENT NOW